Intervention Protocol

Temozolomide for children and adolescents with diffuse intrinsic pontine glioma

  1. Marc HA Jansen1,*,
  2. Susanna JE Veringa1,
  3. Dannis G van Vuurden1,
  4. Elvira C van Dalen2,
  5. Gertjan JL Kaspers1

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 17 OCT 2012

DOI: 10.1002/14651858.CD010129


How to Cite

Jansen MHA, Veringa SJE, van Vuurden DG, van Dalen EC, Kaspers GJL. Temozolomide for children and adolescents with diffuse intrinsic pontine glioma (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD010129. DOI: 10.1002/14651858.CD010129.

Author Information

  1. 1

    VU University Medical Center, Department of Paediatrics, Division of Paediatric Oncology/Haematology, Amsterdam, Netherlands

  2. 2

    Emma Children's Hospital / Academic Medical Center, Department of Paediatric Oncology, Amsterdam, Netherlands

*Marc HA Jansen, Department of Paediatrics, Division of Paediatric Oncology/Haematology, VU University Medical Center, PO Box 7057, Amsterdam, 1007 MB, Netherlands. mh.jansen@vumc.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 17 OCT 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy of temozolomide in children and adolescents with newly diagnosed and progressive DIPG.